The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)
Open accessAbstract
Background: High blood pressure is an important public health concern because it is highly prevalent and a risk factor for adverse health outcomes, including coronary heart disease, stroke, decompensated heart failure, chronic kidney disease, and decline in cognitive function. Observational studies show a progressive increase in risk associated with blood pressure above 115/75 mm Hg. Prior research has shown that reducing elevated systolic blood pressure lowers the risk of subsequent clinical complications from cardiovascular disease. However, the optimal systolic blood pressure to reduce blood pressure–related adverse outcomes is unclear, and the benefit of treating to a level of systolic blood pressure well below 140 mm Hg has not been proven in a large, definitive clinical trial. Purpose: To describe the design considerations of the Systolic Blood Pressure Intervention Trial (SPRINT) and the baseline characteristics of trial participants. Methods: The Systolic Blood Pressure Intervention Trial is a multicenter, randomized, controlled trial that compares two strategies for treating systolic blood pressure: one targets the standard target of <140 mm Hg, and the other targets a more intensive target of <120 mm Hg. Enrollment focused on volunteers of age ≥50 years (no upper limit) with an average baseline systolic blood pressure ≥130 mm Hg and evidence of cardiovascular disease, chronic kidney disease, 10-year Framingham cardiovascular disease risk score ≥15%, or age ≥75 years. The Systolic Blood Pressure Intervention Trial recruitment also targeted three pre-specified subgroups: participants with chronic kidney disease (estimated glomerular filtration rate <60 mL/min/1.73 m 2), participants with a history of cardiovascular disease, and participants 75 years of age or older. The primary outcome is first the occurrence of a myocardial infarction (MI), acute coronary syndrome, stroke, heart failure, or cardiovascular disease death. Secondary outcomes include all-cause mortality, decline in kidney function or development of end-stage renal disease, incident dementia, decline in cognitive function, and small-vessel cerebral ischemic disease. Results: Between 8 November 2010 and 15 March 2013, Systolic Blood Pressure Intervention Trial recruited and randomized 9361 people at 102 clinics, including 3331 women, 2648 with chronic kidney disease, 1877 with a history of cardiovascular disease, 3962 minorities, and 2636 ≥75 years of age. Limitations: Although the overall recruitment target was met, the numbers recruited in the high-risk subgroups were lower than planned. Conclusions: The Systolic Blood Pressure Intervention Trial will provide important information on the risks and benefits of intensive blood pressure treatment targets in a diverse sample of high-risk participants, including those with prior cardiovascular disease, chronic kidney disease, and those aged ≥75 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,594
Self-citationJames, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Self-citationGeneral Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Rosen, C. B. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278597 · Cited by 6,593
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Rosen, R., Cappelleri, J., Smith, M., Lipsky, J., & Peña, B. (1999) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900472 · Cited by 3,053
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989
Measurement of Functional Activities in Older Adults in the Community
Pfeffer, R. I., Kurosaki, T. T., Harrah, C. H., Chance, J. M., & Filos, S. (1982) · Journal of Gerontology · doi:10.1093/geronj/37.3.323 · Cited by 2,972
The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores
WIEGEL, M., MESTON, C., & ROSEN, R. (2005) · Journal of Sex & Marital Therapy · doi:10.1080/00926230590475206 · Cited by 2,396
Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328
The progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155
Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease
Vasan, R. S., Larson, M. G., Leip, E. P., Evans, J. C., O'Donnell, C. J., Kannel, W. B., & Levy, D. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003417 · Cited by 2,082
Development and initial validation of the Falls Efficacy Scale-International (FES-I)
Yardley, L., Beyer, N., Hauer, K., Kempen, G., Piot-Ziegler, C., & Todd, C. (2005) · Age and Ageing · doi:10.1093/ageing/afi196 · Cited by 2,066
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
Dahlöf, B., Hansson, L., Lindholm, L. H., Scherstén, B., Ekbom, T., & Wester, P.-O. (1991) · The Lancet · doi:10.1016/0140-6736(91)92589-t · Cited by 1,881
Easton, J. D., Saver, J. L., Albers, G. W., Alberts, M. J., Chaturvedi, S., Feldmann, E., Hatsukami, T. S., Higashida, R. T., Johnston, S. C., Kidwell, C. S., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.192218 · Cited by 1,845
The J-Curve Phenomenon in Hypertension
Kang, Y.-Y., & Wang, J.-G. (2016) · Pulse · doi:10.1159/000446922 · Cited by 1,530
Forette, F., Seux, M.-L., Staessen, J. A., Thijs, L., Birkenhäger, W. H., Babarskiene, M.-R., Babeanu, S., Bossini, A., Gil-Extremera, B., Girerd, X., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03086-4 · Cited by 1,441
Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis
Lindholm, L. H., Carlberg, B., & Samuelsson, O. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67573-3 · Cited by 999
(2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1069 · Cited by 988
Psaty, B. M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540330061036 · Cited by 875
Luepker, R. V., Apple, F. S., Christenson, R. H., Crow, R. S., Fortmann, S. P., Goff, D., Goldberg, R. J., Hand, M. M., Jaffe, A. S., Julian, D. G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000100560.46946.ea · Cited by 810
Self-citationPeters, R., Beckett, N., Forette, F., Tuomilehto, J., Clarke, R., Ritchie, C., Waldman, A., Walton, I., Poulter, R., Ma, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70143-1 · Cited by 770 · cited 1×
“HYVET also had an intriguing but non-significant impact on cognition as the study was stopped early.(67) In addition, recent guidelines(68,69) have questioned the ideal SBP target for older individuals.”
BackgroundBlood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial
(2013) · The Lancet · doi:10.1016/s0140-6736(13)60852-1 · Cited by 749
Franklin, S. S., Jacobs, M. J., Wong, N. D., L’Italien, G. J., & Lapuerta, P. (2001) · Hypertension · doi:10.1161/01.hyp.37.3.869 · Cited by 706
Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12)
Selim, A. J., Rogers, W., Fleishman, J. A., Qian, S. X., Fincke, B. G., Rothendler, J. A., & Kazis, L. E. (2009) · Quality of Life Research · doi:10.1007/s11136-008-9418-2 · Cited by 602
The Minnesota Code Manual of Electrocardiographic Findings
Prineas, R. J., Crow, R. S., & Zhang, Z.-M. (2010) · Springer eBooks · doi:10.1007/978-1-84882-778-3 · Cited by 563
Management of hypertension: summary of NICE guidance
Krause, T., Lovibond, K., Caulfield, M., McCormack, T., Williams, B., & on behalf of the Guideline Development Group (2011) · BMJ · doi:10.1136/bmj.d4891 · Cited by 477
Hsu, C.-Y., McCulloch, C. E., Darbinian, J., Go, A. S., & Iribarren, C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.8.923 · Cited by 473
Ay, H., Benner, T., Murat Arsava, E., Furie, K. L., Singhal, A. B., Jensen, M. B., Ayata, C., Towfighi, A., Smith, E. E., Chong, J. Y., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.490896 · Cited by 455
Ernst, M. E., Carter, B. L., Goerdt, C. J., Steffensmeier, J. J. G., Phillips, B. B., Zimmerman, M. B., & Bergus, G. R. (2006) · Hypertension · doi:10.1161/01.hyp.0000203309.07140.d3 · Cited by 433
Race-Ethnic Disparities in the Impact of Stroke Risk Factors: The Northern Manhattan Stroke Study
Sacco, R. L., Boden-Albala, B., Abel, G., Lin, I.-F., Elkind, M., Hauser, W. A., Paik, M. C., & Shea, S. (2001) · Stroke · doi:10.1161/01.str.32.8.1725 · Cited by 376
Hypertension and the Risk of Mild Cognitive Impairment
Reitz, C., Tang, M.-X., Manly, J., Mayeux, R., & Luchsinger, J. A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.12.1734 · Cited by 360
The Role of Diastolic Blood Pressure When Treating Isolated Systolic Hypertension
Somes, G. W., Pahor, M., Shorr, R. I., Cushman, W. C., & Applegate, W. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.17.2004 · Cited by 352
Self-citationRosamond, W. D., Chang, P. P., Baggett, C., Johnson, A., Bertoni, A. G., Shahar, E., Deswal, A., Heiss, G., & Chambless, L. E. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.963199 · Cited by 349
Greenlund, K. J., Croft, J. B., & Mensah, G. A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2113 · Cited by 324
Minnesota Code Manual of Electrocardiographic Findings
Marty, A. T. (1983) · Critical Care Medicine · doi:10.1097/00003246-198307000-00029 · Cited by 310
Update on hypertension and Alzheimer's disease
Skoog, I., & Gustafson, D. (2006) · Neurological Research · doi:10.1179/016164106x130506 · Cited by 294
Cardiovascular risk factors and Alzheimer’s disease
Luchsinger, J. A., & Mayeux, R. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0056-z · Cited by 238
A Validation Study of the Dementia Questionnaire
Kawas, C., Segal, J., Stewart, W. F., Corrada, M., & Thal, L. J. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210073015 · Cited by 231
Statistical Monitoring of Clinical Trials
Proschan, M. A., Lan, K. G., & Wittes, J. T. (2006) · Springer eBooks · doi:10.1007/978-0-387-44970-8 · Cited by 201
SKOOG, I., LITHELL, H., HANSSON, L., ELMFELDT, D., HOFMAN, A., OLOFSSON, B., TRENKWALDER, P., & ZANCHETTI, A. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.02.013 · Cited by 199
Statistical Monitoring of Clinical Trials: a Unified Approach
Chernick, M. R. (2007) · Technometrics · doi:10.1198/tech.2007.s479 · Cited by 186
Guidelines on preventing cardiovascular disease in clinical practice
Jackson, R. (2000) · BMJ · doi:10.1136/bmj.320.7236.659 · Cited by 160
Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke
Gordon, D., Bendixen, B. H., Adams, H. P., Clarke, W. R., Kappelle, L. J., Woolson, R. F., & TOAST Investigators (1993) · Neurology · doi:10.1212/wnl.43.5.1021 · Cited by 150
Successful Blood Pressure Control in the African American Study of Kidney Disease and Hypertension
Wright, J. T., AGODOA, L. C. Y., Contreras, G. N., Greene, T., Douglas, J. G., Lash, J. P., Randall, O. S., Rogers, N., Smith, M. C. F., & Massry, S. G. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.14.1636 · Cited by 149
Self-citationHypertension, hypertension-clustering factors and Alzheimer's disease
Skoog, I. G., & Gustafson, D. (2003) · Neurological Research · doi:10.1179/016164103101201986 · Cited by 120
Validation of a Cognitive Assessment Battery Administered over the Telephone
Rapp, S. R., Legault, C., Espeland, M. A., Resnick, S. M., Hogan, P. E., Coker, L. H., Dailey, M., Shumaker, S. A., & The CAT Study Group (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04111.x · Cited by 111
Self-citationCardiovascular disease in the United States: an epidemiologic overview.
Gillum, R. F. (1991) · PubMed · Cited by 84
Antihypertensive Treatment and the J-curve
Cruickshank, J. M. (2000) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007856014581 · Cited by 67
Cruickshank, J. M., Pennert, K. M., rman, A. E. S., Thorp, J. M., Zacharias, F. M., & Zacharias, F. J. (1987) · Journal of Hypertension · doi:10.1097/00004872-198708000-00016 · Cited by 57
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citationA Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Self-citationWilliamson, J. D., Supiano, M. A., Applegate, W. B., Berlowitz, D. R., Campbell, R. C., Chertow, G. M., Fine, L. J., Haley, W. E., Hawfield, A. T., Ix, J. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.7050 · Cited by 1,261
Self-citation
Metadata
- Authors
- Ambrosius, W. T., Sink, K. M., Foy, C. G., Berlowitz, D. R., Cheung, A. K., Cushman, W. C., Fine, L. J., Goff, D. C., Johnson, K. C., Killeen, A. A., Lewis, C. E., Oparil, S., Reboussin, D. M., Rocco, M. V., Snyder, J. K., Williamson, J. D., Wright, J. T., Whelton, P. K., & The SPRINT Study Research Group
- Venue
- Clinical Trials
- Publisher
- SAGE Publications
- Published
- 2014-06-05
- Volume
- 11
- Issue
- 5
- Pages
- 532-546
- ISSN
- 1740-7745 (ISSN-L)
- 1740-7753
- OpenAlex
- W2092075924
- Cited by
- 544
- References
- 66
- FWCI
- 30.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.